S

Sequana Medical NV
SEQUA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€57.44M
EV
€93.74M
Shares Outstanding
57.34M
Beta
-0.07

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€3.97
P/E 2025E
-
P/Revenue 2025E
88.37x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Sequana Medical NV

gainify

S

Sequana Medical NV

SEQUA

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump sy...

Sector

Healthcare

Industry

Medical - Devices

CEO

Crosbie, Ian

Employees

48

IPO Date

2019-02-11

Headquarters

Kortrijksesteenweg 1112, box 102, Sint-Denijs-Westrem, Gent, East Flanders, 9051, Belgium

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.